Xenta Biomedical
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- Undisclosed
Investors
- 3
About Xenta Biomedical
Founded in 2022 and headquartered in Shenzhen, China, Xenta Biomedical specializes in biotechnology solutions for health enhancement. The company has completed one significant deal, with the most recent transaction occurring in October 2025.Xenta Biomedical specializes in the development and delivery of innovative biotechnology products aimed at enhancing health and wellness. Their core product offerings include advanced biopharmaceuticals and personalized healthcare solutions designed to address specific medical conditions. These products are formulated using proprietary technologies that focus on optimizing therapeutic efficacy and minimizing side effects. Notable applications encompass treatments for chronic diseases such as diabetes and cardiovascular disorders, which are prevalent in many global markets, including North America and Europe.Xenta Biomedical's revenue model is structured around a combination of B2B partnerships and direct-to-consumer sales. Transactions typically involve healthcare organizations purchasing biopharmaceutical products on a subscription basis, allowing for regular supply and continuous access to innovative treatments. Retailers also play a pivotal role in distributing these products to consumers, broadening the market reach. Flagship products, which may include trademarked therapies, are marketed at competitive pricing tiers aimed at ensuring accessibility while maintaining profitability. Additionally, the funds will bolster investments in new product research and development, further enhancing the company's testing capabilities. Overall, the company aims to launch new products and expand into new markets, enhancing its global footprint.
Who invested in Xenta Biomedical
3 investors across 1 round
See all investors in Xenta Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 17, 2025
Amount
Undisclosed
Investors
Questions about Xenta Biomedical
Who invested in Xenta Biomedical?
Xenta Biomedical has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xenta Biomedical raised?
Xenta Biomedical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Xenta Biomedical last raise money?
Xenta Biomedical's most recent round on record is a Series A, in Oct 2025.
What does Xenta Biomedical do?
Founded in 2022 and headquartered in Shenzhen, China, Xenta Biomedical specializes in biotechnology solutions for health enhancement.
Where is Xenta Biomedical headquartered?
Xenta Biomedical is headquartered in Shenzhen, China.
Which VCs invest in companies like Xenta Biomedical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Xenta Biomedical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Xenta Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.